181 related articles for article (PubMed ID: 33176636)
1. A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options.
Suhail M; Tarique M; Muhammad N; Naz H; Hafeez A; Zughaibi TA; Kamal MA; Rehan M
Curr Med Chem; 2021; 28(21):4117-4132. PubMed ID: 33176636
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of NF-kappaB signaling: 785 and counting.
Gilmore TD; Herscovitch M
Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
4. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
[TBL] [Abstract][Full Text] [Related]
5. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer.
Eskandani R; Kazempour M; Farahzadi R; Sanaat Z; Eskandani M; Adibkia K; Vandghanooni S; Mokhtarzadeh A
Biomed Pharmacother; 2022 Dec; 156():113932. PubMed ID: 36411621
[TBL] [Abstract][Full Text] [Related]
6. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.
Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z
Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325
[TBL] [Abstract][Full Text] [Related]
7. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
8. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase.
Zhang L; Cui R; Cheng X; Du J
Cancer Res; 2005 Jan; 65(2):457-64. PubMed ID: 15695387
[TBL] [Abstract][Full Text] [Related]
9. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
11. Medicinal Plants in Cancer Treatment: Contribution of Nuclear Factor- Kappa B (NF-kB) Inhibitors.
Das R; Mehta DK; Dhanawat M
Mini Rev Med Chem; 2022; 22(15):1938-1962. PubMed ID: 35260052
[TBL] [Abstract][Full Text] [Related]
12. Hit identification of IKKβ natural product inhibitor.
Leung CH; Chan DS; Li YW; Fong WF; Ma DL
BMC Pharmacol Toxicol; 2013 Jan; 14():3. PubMed ID: 23294515
[TBL] [Abstract][Full Text] [Related]
13. Targeting the NF-κB pathway in cancer therapy.
Erstad DJ; Cusack JC
Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Gupta SC; Sundaram C; Reuter S; Aggarwal BB
Biochim Biophys Acta; 2010; 1799(10-12):775-87. PubMed ID: 20493977
[TBL] [Abstract][Full Text] [Related]
15. A20-mediated negative regulation of canonical NF-κB signaling pathway.
Pujari R; Hunte R; Khan WN; Shembade N
Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy.
Pande V; Ramos MJ
Curr Med Chem; 2003 Aug; 10(16):1603-15. PubMed ID: 12871131
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy.
Li X; Wu Z; An X; Mei Q; Bai M; Hanski L; Li X; Ahola T; Han W
Elife; 2017 Aug; 6():. PubMed ID: 28820388
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
19. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
20. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
Freitas RHCN; Fraga CAM
Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
